MapLight Therapeutics, Inc. (NASDAQ:MPLT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Martin Babler Other companies: Alumis Inc. (President, Chief Executive Officer and Chairman of the Board · Since at least Jun 27, 2024); 89bio Inc (Director · Since at least Apr 13, 2024); Prelude Therapeutics Incorporated (Director · Since at least Jul 19, 2021); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Neurogene Inc. (Director · Sep 8, 2020 – Jun 8, 2023 · Past); Principia Biopharma Inc (President, CEO, Director · Sep 13, 2018 – Sep 28, 2020 · Past); ZS Pharma Inc (Director · Mar 19, 2015 – Dec 17, 2015 · Past) | Member of the Audit Committee · Since at least Jun 23, 2026 |
| Troy Cox Other companies: Sophia Genetics SA (Board Member and Lead Independent Director · Since at least Mar 18, 2026); Standard BioTools Inc. (Director · Since at least Jan 5, 2024); Zymeworks Inc. (Director · Jun 3, 2019 – Dec 10, 2024 · Past); Foundation Medicine Inc (President and CEO, Director · Feb 6, 2017 – Jul 31, 2018 · Past) | Chair of the Nominating and Corporate Governance Committee · Since at least Jun 23, 2026 |
| George Pavlov Other companies: Audience Inc (Director · May 8, 2012 – Jul 1, 2015 · Past); Ikanos Communications Inc (Director · Aug 24, 2009 – Sep 28, 2015 · Past) | Board Member · Since at least Oct 25, 2025 |
| Maria Walker Other companies: Five9, Inc. (Director · Since at least May 21, 2024); ForgeRock Inc (Director · Sep 15, 2021 – Aug 23, 2023 · Past) | Chair of the Audit Committee · Since at least Oct 25, 2025 |
| Christopher Kroeger Other companies: Tempest Therapeutics, Inc. (Chief Executive Officer · Sep 1, 2017 – Dec 7, 2018 · Past) | Chief Executive Officer, Founder, Board Member · Since at least Oct 25, 2025 |
| James Lillie Other companies: Tempest Therapeutics, Inc. (Chief Scientific Officer · Jan 16, 2018 – Dec 7, 2018 · Past) | Chief Scientific Officer · Since at least Oct 25, 2025 |
| Jonathan Gillis Other companies: Tempest Therapeutics, Inc. (Senior Vice President, Finance · Jun 21, 2017 – Dec 7, 2018 · Past) | Interim Chief Financial Officer, Chief Administrative and Accounting Officer · Since at least Oct 25, 2025 |
| Kristopher Hanson Other companies: PhaseBio Pharmaceuticals Inc (SVP and General Counsel · Nov 20, 2020 – May 20, 2022 · Past) | General Counsel · Since at least Oct 25, 2025 |
| Anatol Kreitzer | Chief Discovery Officer · Since at least Oct 25, 2025 |
| Erin Pennock Foff | Chief Medical Officer · Since at least Apr 15, 2026 |
| James D Trenkle | Director · Since at least Oct 25, 2025 |
| Karl Deisseroth | Founder, Scientific Advisory Board · Since at least Oct 6, 2026 |
| Kris Hanson | General Counsel · Since at least Oct 16, 2026 |
| Nanna Lüneborg | General Partner at Forbion, Board Member · Since at least Oct 25, 2025 |
| Robert Malenka | Founder, Board of Directors, Scientific Advisory Board · Since at least Oct 25, 2025 |
| Timothy Garnett | Director · Since at least Oct 25, 2025 |
| Vishwas Setia | Chief Financial Officer · Since at least Oct 25, 2025 |